Medicine and Dentistry
Mesenchymal-Epithelial Transition
63%
Gene
54%
Patient
48%
PET-CT
45%
26 Hydroxycholesterol
45%
Breast Cancer Resistance Protein
45%
Parathyroid
45%
Tissues
37%
Cholesterol
36%
Cells
34%
Thyroid Gland
29%
Thyroid Tumor
27%
Neoplasm
23%
Lymph Node
22%
Fluorine-18
22%
Cell Migration
22%
Thyroid Carcinoma
19%
Low-Density Lipoprotein
18%
Metabolite
18%
Cholesterol Metabolism
18%
Inflammatory Mediator
17%
Cancer Stem Cell
17%
Single Photon Emission Computed Tomography-Computed Tomography
15%
Technetium-99
15%
Primary Hyperparathyroidism
15%
Scintigraphy
15%
Inpatient
15%
Aggression
14%
Gene Expression
13%
Uvomorulin
13%
Tissue Injury
13%
Differentiation
13%
Serositis
11%
Association
11%
Cancer Cell
11%
Combination Therapy
9%
CAL-62 Cell Line
9%
Thyroid Papillary Carcinoma Cell Line
9%
Cell Proliferation
9%
Serum
9%
Blood
9%
Endometrial Cancer
9%
Anaplastic Thyroid Carcinoma
9%
Oxygenase
9%
Poorly Differentiated Thyroid Cancer
9%
Low Density Lipoprotein Cholesterol
9%
Breast Cancer
9%
Cellular Model
9%
Thyroid Cancer
9%
Apolipoprotein B
9%
Biochemistry, Genetics and Molecular Biology
Nested Gene
100%
Gene Expression
59%
Upregulation
54%
Cholesterol
45%
27-Hydroxycholesterol
45%
Proteomics
45%
Sorafenib
45%
Protein
45%
Low-Density Lipoprotein
36%
Electric Potential
22%
Cell Migration
22%
ABCG2
22%
down Regulation
22%
Protein Expression
22%
Papillary Tumor
22%
Voltage-Dependent Anion Channel
22%
Quantitative Reverse Transcription Polymerase Chain Reaction
22%
Mesenchymal-Epithelial Transition
18%
ZEB1
18%
Cholesterol Metabolism
18%
Aggression
9%
Vimentin
9%
Inducer
9%
Aggressiveness
9%
Cell Proliferation
9%
Apolipoprotein B
9%
Reductase
9%
Lipoprotein Blood Level
9%
Pharmacology, Toxicology and Pharmaceutical Science
26 Hydroxycholesterol
45%
ABCG2
45%
Cholesterol
36%
Thyroid Tumor
27%
Low Density Lipoprotein
18%
Neoplasm
18%
Thyroid Carcinoma
13%
Uvomorulin
13%
25 Hydroxycholesterol
9%
Anaplastic Thyroid Carcinoma
9%
Poorly Differentiated Thyroid Cancer
9%
Low Density Lipoprotein Cholesterol
9%
Thyroid Cancer
9%
Endometrium Cancer
9%
Prognosis
9%
Oxidoreductase
9%
Low Density Lipoprotein Receptor
9%
Breast Cancer
9%
Apolipoprotein B
9%
Thyroid Papillary Carcinoma
9%
Oxygenase
9%
Lipoprotein
9%
Chemotherapy
9%
Vimentin
9%
Nerve Cell Adhesion Molecule
9%